Product Images Divalproex Sodium ER

This is a container label for Divalproex Sodium Extended-Release Tablets with 250mg strength per tablet. Each tablet contains Divalproex and sodium equivalent to valproic acid. It also includes manufacturer and distributor information, as well as instructions not to accept the bottle if the seal is broken. The label advises dispensing in a USP tight, light-resistant container and the pharmacist should provide a Patient Information Sheet. There is an enclosure with prescribing information. Size of the label is 105mm x 45mm.*

This is a container label for Divalproex Sodium Extended-Release Tablets, containing 100 tablets of 500 mg each. It includes important product information such as the drug's active ingredient and equivalent amount, as well as pharmaceutical prescribing and dispensary instructions. The label also displays a warning not to use the product if the seal is broken or missing. The product should be dispensed in a USP tight, light-resistant container. The label includes the manufacturer's contact details, and its size is 115mm x 55mm.*

The text is describing a chart showing the percentage reduction in CPS (cycles per second) rate for patients taking divalproex sodium delayed-release tablets compared to a placebo. The chart also includes the percentage of patients who showed improvement, no change, or worsening in their CPS rate.*

This text appears to be a graph showing the percentage of patients who experienced a reduction in CPS Ratk with high dose and low dose divalproex sodium delayed-release tablets. The graph indicates that 50% of patients experienced improvement while the remaining patients experienced either no improvement or worsening. There is not enough information to determine the context (e.g. what CPS Ratk is, what condition the tablets are treating, etc.).*